Systematic review of pharmacologic treatment in fibromyalgia;Revisión sistemática de las intervenciones farmacológicas en la fibromialgia

Medicina Clinica

Volumn 125, Issue 20, 2005, Pages 784-787

  Alegre De Miquel, Cayetano ^a   Alejandra Pereda, Claudia ^b   Betina Nishishinya, María ^c   Rivera, Javier ^d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Mediterranea Medica Clinic   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; ALPRAZOLAM; AMITRIPTYLINE; CITALOPRAM; CLOMIPRAMINE; CYCLOBENZAPRINE; FLUOXETINE; FLURAZEPAM; MAPROTILINE; NORTRIPTYLINE; PARACETAMOL; PLACEBO; RITANSERIN; S ADENOSYLMETHIONINE; SEROTONIN UPTAKE INHIBITOR; TRAMADOL; TRICYCLIC ANTIDEPRESSANT AGENT; TROPISETRON; VITAMIN D; ZOLPIDEM;

ARTICLE; CHRONIC FATIGUE SYNDROME; EVIDENCE BASED MEDICINE; EXERCISE; FIBROMYALGIA; FIBROSITIS; HUMAN; PATHOPHYSIOLOGY; SYSTEMATIC REVIEW;

EID: 29944439333     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(05)72190-4     Document Type: Article

References (37)

1. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum. 2000;43:2823-33.
2. Russel IJ. Is fibromyalgia a distinct clinical entity? The clinical investigator's evidence. Baill Clin Rheumatol. 1999;13:445-54.
3. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004;292:2388-95.
4. Hadhazy VA, Ezzo J, Creamer P, Berman BM. Mind-body therapies for the treatment of fibromyalgia. A systematic review. J Rheumatol. 2000; 27:2911-8.
5. Busch A, Schachter CL, Peloso PM, Bombardier C. Exercise for treating fibromyalgia syndrome. (Cochrane Review). En: The Cochrane Library, Issue 4. Chichester: John Wiley & Sons, Ltd.; 2004.
6. Collado Cruz A, Torres i Mata X, Arias i Gassol A, Cerdà Gabaroi D, Vilarrasa R, Valdés Miyar M, et al. Eficacia del tratamiento multidisciplinario del dolor crónico incapacitante del aparato locomotor. Med Clin (Barc). 2001;117:401-5.
7. Collado A, Alijotas J, Benito P, Alegre C, Romera M, Sañudo I, et al. Documenta de consenso sobre el diagnóstico y tratamiento de la fibromialgia en Cataluña. Med Clin (Barc). 2002;118:745-9.
8. Junyent Priu M, Camp Herrero J, Fernández Solà J. Utilización de la medicina alternativa y complementaria en la fibromialgia. Med Clin (Barc). 2005;124:397.
9. Holdcraft LC, Assefi N, Buchwald D. Complementary and alternative medicine in fibromyalgia and related syndromes. Best Pract Res Clin Rheumatol. 2003;17:667-83.
10. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
11. Baraczka K, Janko Z, Vargha K, Markus H. Clinical experiences with the analgesic effects of citalopram. Orv Hetil. 1997;138:2605-7.
12. Cantini F, Bellandi F, Niccoli L, Di Munno O. Fluoxetin combined with cyclobenzaprine in the treatment of fibromyalgia. Minerva Med. 1994; 85:97-100.
13. Sogtrop HH, Weise HT. Results of treatment with DoloVisano for non-specific pain syndrome related to body movement. Concluding report on a field study of 3326 patients by 314 orthopedists. Fortschr Med. 1979;97:791-6.
14. Santandrea S, Montrone F, Sarzi-Puttini P, Boccassini L, Caruso I. A double-blind crossover study of two cyclobenzaprine regimens in primary fibromyalgia syndrome. J Int Med Res. 1993;21:74-80.
15. Haus U, Varga B, Stratz T, Spath M, Muller W. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol Suppl. 2000;113:55-8.
16. Citera G, Arias MA, Maldonado-Cocco JA, Lazaro MA, Rosemffet MG, Brusco L, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol. 2000;19:9-13.
17. Tavoni A, Jeracitano G, Cirigliano G. Evaluation of S-adenosylmethionine in secondary fibromyalgia: a double-blind study. Clin Exp Rheumatol. 1998;16:106-7.
18. Farber L, Stratz T, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia-a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl. 2000;113:49-54.
19. Rossy LA, Buckelew SP, Dorr N, Hagglund KJ, Thayer JF, McIntosh MJ, et al. A meta-analysis of fibromyalgia treatment interventions. Ann Behav Med. 1999;21:180-91.
20. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics. 2000;41:104-13.
21. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenke K, Jackson JL Treatment of fibromyalgia with antidepressants: a meta-analysis. J Gen Intern Med. 2000;15:659-66.
22. Bennett RM, Kamin M, Karim R, Rosenthal N. Tramadol and acetaminophen combination tablets in the treatment of fibromialgia pain: a double-blind, randomized, placebo-controlled study. Am J Med. 2003;114:537-45.
23. Biasi G, Manca S, Manganelli S, Marcolongo R. Tramadol in the fibromyalgia syndrome: a controlled clinical trial versus placebo. Int J Clin Pharmacol Res. 1998;18:13-9.
24. Tofferi JK, Jackson JL, O'Malley PG. Treatment of fibromyalgia with cyclobenzaprine: a meta-analysis. Arthritis Rheum. 2004;51:9-13.
25. Heymann RE, Helfenstein M, Feldman D. A double-blind, randomized, controlled study of amitriptyline, nortriptyline and placebo in patients with fibromyalgia. An analysis of outcome measures. Clin Exp Rheumatol. 2001;19:697-702.
26. Jung AC, Staiger T, Sullivan M. The efficacy of selective serotonin reuptake inhibitors for the management of chronic pain. J Gen Intern Med. 1997;12:384-9.
27. Wolfe F, Cathey MA, Hawley DJ. A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol. 1994;23:255-9.
28. Goldenberg DL, Mayskly M, Mossey C, Ruthazer R, Schmid C. A randomised, double blind crossover trial of fluxetine and amytriptiline in the treatment of fibromyalgia. Arthritis Rheum. 1996;39:1852-9.
29. Norregaard J, Volkmann H, Danneskiold-Samsoe B. A randomized controlled trial of citalopram in the treatment of fibromyalgia. Pain. 1995;61:445-9.
30. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE Jr. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191-7.
31. Anderberg UM, Marteinsdottir I, Von Knorring L. Citalopram in patients with fibromyalgia-a randomized, double-blind, placebo-controlled study. Eur J Pain. 2000;4:27-35.
32. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-84.
33. Spath M, Stratz T, Neeck G, Kotter I, Hammel B, Amberger CC, et al. Efficacy and tolerability of intravenous tropisetron in the treatment of fibromyalgia. Scand J Rheumatol. 2004;33:267-70.
34. Farber L, Stratz TH, Bruckle W, Spath M, Pongratz D, Lautenschlager J, et al; German Fibromyalgia Study Group. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients. Int J Clin Pharmacol Res. 2001;21:1-13.
35. Olin R, Klein R, Berg PA. A randomised double-blind 16-week study of ritanserin in fibromyalgia syndrome: clinical outcome and analysis of autoantibodies to serotonin, gangliosides and phospholipids. Clin Rheumatol. 1998;17:89-94.
36. Scharf MB, Baumann M, Berkowitz DV. The effects of sodium oxybate on Clinical symptoms and sleep patterns in patients with fibromyalgia. J Rheumatol. 2003;30:1070-4.
37. Bennett RM, Clark SC, Walczyk J. A randomized, double-blind, placebo-controlled study of growth hormone in the treatment of fibromyalgia. Am J Med. 1998; 104:227-31.